FDA Device recall Z-0055-2020
BD Microtainer Tubes with LH (Lithium Heparin) Part/Catalog No.365965
- FDA Device
- Class II
- terminated
- Published 2019-10-16
On 2019-10-16 the FDA classified a Class II recall of BD Microtainer Tubes with LH (Lithium Heparin) Part/Catalog No.365965 by Becton Dickinson And, citing damaged reservoir may lead to a decreased fill volume causing samples to be insufficient for testing and improper blood-to-additive ratio, potentially producing erroneous results.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0055-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-05-13 |
| Published | 2019-10-16 |
| Last updated | 2026-09-13 11:55 UTC |
| Company | Becton Dickinson And |
| Distribution | US |
Product
BD Microtainer Tubes with LH (Lithium Heparin) Part/Catalog No.365965
Reason
Damaged reservoir may lead to a decreased fill volume causing samples to be insufficient for testing and improper blood-to-additive ratio, potentially producing erroneous results.
Identifiers
| code_info | Lot Number/UDI: 811767N (01)30382903659655 (17)190930(10)811767N(30)50 (17)190930(10)811767N(30)200 (01)5038290365965…Lot Number/UDI: 811767N (01)30382903659655 (17)190930(10)811767N(30)50 (17)190930(10)811767N(30)200 (01)50382903659659 2019-09-30 815066N (01)30382903659655 (17)191130(10)815066N(30)50 (17)191130(10)815066N(30)200 (01)50382903659659 821471N (01)30382903659655 (17)200131(10)821471N(30)50 (17)200131(10)821471N(30)200 (01)50382903659659 821990N (01)30382903659655 (17)200131(10)821990N(30)50 (17)200131(10)821990N(30)200 (01)50382903659659 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0055-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.